Sanziana Roman, MD, FACS

Professor of Clinical Surgery
Surgery
She/Her/Hers

Endocrine surgeon
Dr. Sanziana Roman brings two decades of experience in her surgical treatment of tumors of the adrenal, thyroid, and parathyroid glands. She has a particular interest in minimally invasive approaches to surgery and is one of few surgeons around the world with a high-volume practice in posterior retroperitoneoscopic adrenalectomy (PRA).
In addition, she has vast experience in treating pediatric thyroid nodules and tumors, including children and adolescents with congenital hypothyroidism and goiter, Graves’ disease, thyroid cancer, as well as inherited syndromes, such as Multiple Endocrine Neoplasias.
Dr Roman earned her medical degree at the Columbia University College of Physicians and Surgeons, New York NY, and completed her surgical residency training at Yale University, New Haven, CT. Prior to coming to UCSF, she was the Chief of Endocrine Surgery at Yale University for 13 years, subsequently becoming a tenured professor of surgery and the Associate Chief of the Advanced Oncologic Surgery Division at Duke University, Durham, NC, where she remained on faculty for more than five years. There, she established the Center for Adrenal Disease and the Duke Pediatric Thyroid Center. Dr. Roman has been listed in the publication America’s Top Doctors. She is board certified in surgery.

Dr Roman is a dedicated medical educator and is the Director of Clinical Teaching (F2) and Career Launch (CL) Curricula for medical students in the School of Medicine at UCSF.

Prior to becoming a surgeon, Dr. Roman was an opera singer. She combines her love for singing and surgery by focusing her skills on saving the patient’s voice during neck operations. During the COVID pandemic, she teamed up with the San Francisco Opera and is the inventor of the VOXCV singing mask, which helped many opera singers return safely to live performing during the pandemic. The mask design was a finalist in the US Department of Health and Human Services BARDA Mask Challenge, 2021.